Frameshift Mutations in the Bax Gene Are Not Involved in Development of Ovarian Endometrioid Carcinoma

Modern Pathology

Volumn 16, Issue 10, 2003, Pages 1048-1052

  Cao, Shi Nian ^a   Chang, Ki Hong ^c   Luthra, Rajyalakshmi ^b   Liu, Jinsong ^b  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c NONE

Author keywords

Bax gene; Microsatellite instability; Ovarian endometrioid carcinoma

Indexed keywords

PROTEIN BAX; PROTEIN BCL 2;

ARTICLE; BASE PAIRING; CARCINOGENESIS; COLORECTAL CARCINOMA; CONTROLLED STUDY; DNA SEQUENCE; ENDOMETRIOID CARCINOMA; FEMALE; FRAMESHIFT MUTATION; GENE DELETION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MICROSATELLITE INSTABILITY; OVARY CARCINOMA; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

BCL-2-ASSOCIATED X PROTEIN; CARCINOMA, ENDOMETRIOID; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; ENDOMETRIAL NEOPLASMS; FEMALE; FRAMESHIFT MUTATION; HOSPITALS, UNIVERSITY; HUMANS; IMMUNOENZYME TECHNIQUES; MICROSATELLITE REPEATS; OVARIAN NEOPLASMS; POLYMERASE CHAIN REACTION; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; TUMOR MARKERS, BIOLOGICAL;

EID: 0142103682     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.MP.0000089781.66207.D6     Document Type: Article

References (25)

1. Apte SS, Mattei MG, Olsen BR. Mapping of the human BAX gene to chromosome 19q13.3-q13.4 and isolation of a novel alternatively spliced transcript, BAX delta. Genomics 1995;26:592-4.
2. Miyashita T, Krajewski S, Krajewska M, Wang HG, Lin HK, Liebermann DA, et al. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 1994;9:1799-1805.
3. Krajewski S, Blomqvist C, Franssila K, Krajewska M, Wasenius VM, Niskanen E, et al. Reduced expression of proapoptotic gene Bax is associated with poor response rates to combination chemotherapy and shorter survival in women with metastatic breast adenocarcinoma. Cancer Res 1995;55:4471-8.
4. Wagener C, Bargou RC, Daniel PT, Bommert K, Mapara MY, Royer HD, et al. Induction of the death-promoting gene Bax-alpha sensitizes cultured breast-cancer cells to drug-induced apoptosis. Int J Cancer 1996;67:138-41.
5. Simms LA, Radford-Smith G, Biden KG, Buttenshaw R, Cummings M, Jass JR, et al. Reciprocal relationship between the tumor suppressors p53 and BAX in primary colorectal cancers. Oncogene 1998;17:2003-8.
6. Parsons R, Li GM, Longley MJ, Fang WH, Papadopoulos N, Jen J, et al. Hypermutability and mismatch repair deficiency in RER+ tumor cells. Cell 1993;75:1227-36.
7. Eshleman JR, Markowitz SD. Mismatch repair defects in human carcinogenesis. Hum Mol Genet 1996;5 Suppl:1489-94.
8. Kinzler KW, Vogelstein B. Lessons from hereditary colorectal cancer. Cell 1996;87:159-70.
9. Thibodeau SN, French AJ, Roche PC, Cunningham JM, Tester DJ, Lindor NM, et al. Altered expression of hMSH2 and hMLH1 in tumors with microsatellite instability and genetic alterations in mismatch repair genes. Cancer Res 1996;56:4836-40.
10. Leung SY, Yuen ST, Chung LP, Chu KM, Chan AS, Ho JC. hMLH1 promoter methylation and lack of hMLH1 expression in sporadic gastric carcinomas with high-frequency microsatellite instability. Cancer Res 1999;59:159-64.
11. Kim HS, Lee BL, Woo DK, Bae SI, Kim WH. Assessment of markers for the identification of microsatellite instability phenotype in gastric neoplasms. Cancer Lett 2001;164:61-8.
12. Rampino N, Yamamoto H, Ionov Y, Li Y, Sawai H, Reed JC, et al. Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype. Science 1997;275:967-9.
13. Ouyang H, Furukawa T, Abe T, Kato Y, Horii A. The BAX gene, the promoter of apoptosis, is mutated in genetically unstable cancers of the colorectum, stomach, and endometrium. Clin Cancer Res 1998;4:1071-4.
14. Tubbs RR, Sheibani K. Immunohistology of lymphoproliferative disorder. Semin Diagn Pathol 1984;1:272-84.
15. Aaltonen LA, Peltomaki P, Leach FS, Sistonen P, Pylkkanen L, Mecklin JP, et al. Clues to the pathogenesis of familial colorectal cancer. Science 1993;260:812-6.
16. Thibodeau SN, Bren G, Schaid D. Microsatellite instability in cancer of the proximal colon. Science 1993;260:816-9.
17. Ionov Y, Peinado MA, Malkhosyan S, Shibata D, Perucho M. Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature 1993;363:558-61.
18. Strand M, Prolla TA, Liskay RM, Petes TD. Destabilization of tracts of simple repetitive DNA in yeast by mutations affecting DNA mismatch repair. Nature 1993;365:274-6.
19. Abe T, Ouyang H, Migita T, Kato Y, Kimura M, Shiiba K, et al. The somatic mutation frequency of the transforming growth factor beta receptor type II gene varies widely among different cancers with microsatellite instability. Eur J Surg Oncol 1996;22:474-7.
20. Souza RF, Appel R, Yin J, Wang S, Smolinski KN, Abraham JM, et al. Microsatellite instability in the insulin-like growth factor II receptor gene in gastrointestinal tumours. Nat Genet 1996;14:255-7.
21. Ouyang H, Shiwaku HO, Hagiwara H, Miura K, Abe T, Kato Y, et al. The insulin-like growth factor II receptor gene is mutated in genetically unstable cancers of the endometrium, stomach, and colorectum. Cancer Res 1997;57:1851-4.
22. Esteller M, Catasus L, Matias-Guiu X, Mutter GL, Prat J, Baylin SB, et al. hMLH1 promoter hypermethylation is an early event in human endometrial tumorigenesis. Am J Pathol 1999;155:1767-72.
23. Peltomäki P, Vasen HFA. Mutations predisposing to hereditary nonpolyposis colorectal cancer: database and results of a collaborative study. Gastroenterology 1997;113:1146-58.
24. Gras E, Catasus L, Arguelles R, Moreno-Bueno G, Palacios J, Gamallo C, et al. Microsatellite instability, MLH-1 promoter hypermethylation, and frameshift mutations at coding mononucleotide repeat microsatellites in ovarian tumors. Cancer 2001;92:2829-36.
25. Colella G, Vikhanskaya F, Codegoni AM, Bonazzi C, D'Incalci M, Broggini M. hMLH1 and hMSH2 expression and Bax frameshift mutations in ovarian cancer cell lines and tumors. Carcinogenesis 1998;19:691-4.